M. Hoshino

发表

Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients

A. Irisawa, H. Ohira, T. Anazawa, 2012, Journal of hepato-biliary-pancreatic sciences.

Serum Nitric Oxide as a Predictive Biomarker for Bevacizumab in Non-small Cell Lung Cancer Patients.

H. Takagi, Yuzuru Watanabe, M. Higuchi, 2017, Anticancer research.

Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden

T. Isogai, H. Nanamiya, Shinya Watanabe, 2021, Oncology letters.

Clinical significance of expanded Foxp3+ Helios− regulatory T cells in patients with non-small cell lung cancer

Yuzuru Watanabe, M. Higuchi, Hiroyuki Suzuki, 2015, International journal of oncology.

Prognostic value of peripheral and local forkhead box P3+ regulatory T cells in patients with non-small-cell lung cancer.

M. Higuchi, Hiroyuki Suzuki, M. Gotoh, 2014, Molecular and clinical oncology.

Recent advances in immunotherapy for non-small-cell lung cancer

Yuzuru Watanabe, M. Higuchi, Hiroyuki Suzuki, 2014, Human vaccines & immunotherapeutics.

A case of thymic carcinoid detected by FDG-PET

M. Higuchi, Hiroyuki Suzuki, M. Gotoh, 2006 .

Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004).

M. Nishimura, H. Dosaka-akita, T. Kojima, 2021, Lung cancer.

The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study

H. Takagi, M. Higuchi, Hiroyuki Suzuki, 2021, Cancer Immunology, Immunotherapy.

Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancer.

H. Takagi, Yuzuru Watanabe, M. Higuchi, 2018, Fukushima journal of medical science.

BRM cocktail treatment using PSK and OK432 significantly up-regulates the migration activity in human dendritic cells without losing effective CTL induction

M. Higuchi, Hiroyuki Suzuki, M. Gotoh, 2011 .

An invasive thymoma accompanied by high levels of serum squamous cell carcinoma antigen and myasthenia gravis

M. Higuchi, Hiroyuki Suzuki, J. Osugi, 2014 .

[Renal-salt wasting syndrome in a patient with CDDP containing chemotherapy for recurrent non-small-cell lung cancer].

S. Midorikawa, M. Higuchi, Hiroyuki Suzuki, 2011, Gan to kagaku ryoho. Cancer & chemotherapy.

The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial

M. Munakata, H. Takagi, Yuzuru Watanabe, 2017, Trials.

CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC

H. Takagi, M. Higuchi, Hiroyuki Suzuki, 2021, AntiCancer Research.

Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer

T. Isogai, H. Nanamiya, Shinya Watanabe, 2019, Cancer Immunology, Immunotherapy.

Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report

Yuki Matsumura, Takuya Inoue, Takao Isogai, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor

Shinya Watanabe, H. Takagi, S. Waguri, 2017, Oncology letters.

Understanding the response of dendritic cells to activation by streptococcal preparation OK-432.

M. Terashima, Takahiro Saito, M. Gotoh, 2005, Anticancer research.

Efficacy of Immune-checkpoint Inhibitors as the Peri-operative Treatment for Resectable Non-small-cell Lung Cancer

H. Takagi, M. Higuchi, Hiroyuki Suzuki, 2021, Haigan.

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers

H. Takagi, M. Higuchi, Hiroyuki Suzuki, 2023, Biomedicines.

Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma.

H. Takagi, M. Higuchi, Hiroyuki Suzuki, 2020, Oncology letters.

Abstract. Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are an approved first‐line therapy against unresectable or advanced non-small cell lung cancer (NSCLC) harboring EGFR gene activating mutations

H. Takagi, M. Higuchi, Hiroyuki Suzuki, 2020 .

Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma.

Yuzuru Watanabe, M. Higuchi, Hiroyuki Suzuki, 2017, Interactive cardiovascular and thoracic surgery.

Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer

K. Takeda, M. Higuchi, Hiroyuki Suzuki, 2013, Journal of Translational Medicine.

Efficacy and tolerability of nanoparticle albumin-bound paclitaxel in combination with carboplatin as a late-phase chemotherapy for recurrent and advanced non-small-cell lung cancer: A multi-center study of the Fukushima lung cancer association group of surgeons.

H. Takagi, Yuzuru Watanabe, M. Higuchi, 2017, Oncology letters.

A case of thoracoscopic resection of pulmonary alveolar soft part sarcoma

M. Higuchi, Hiroyuki Suzuki, M. Gotoh, 2000 .

Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccination

T. Tsunoda, R. Suzuki, K. Takeda, 2018, Cancer Immunology, Immunotherapy.

Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma

Yuzuru Watanabe, M. Higuchi, Hiroyuki Suzuki, 2015, Journal of oncology.

Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.

Hiroyuki Suzuki, M. Gotoh, J. Osugi, 2015, Lung cancer.

A case of eosinophilic granuloma with right spontaneous pneumothorax

M. Higuchi, Hiroyuki Suzuki, M. Gotoh, 2007 .

Epidermal growth factor receptor gene mutation as risk factor for recurrence in patients with surgically resected lung adenocarcinoma: a matched-pair analysis.

T. Ohira, M. Higuchi, Hiroyuki Suzuki, 2016, Interactive cardiovascular and thoracic surgery.

Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer

K. Takeda, M. Higuchi, Hiroyuki Suzuki, 2013, Journal of Translational Medicine.

A case of pulmonary actinomycosis differentially diagnosed from pulmonary aspergillosis with massive hemoptysis

M. Higuchi, Hiroyuki Suzuki, S. Muto, 2015 .

Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients

A. Irisawa, H. Ohira, T. Anazawa, 2012, Journal of hepato-biliary-pancreatic sciences.